There exists a paucity of structural innovation and limited molecular diversity associated with
molecular frameworks in drug discovery and biomolecular imaging/chemical probe design …

In this review, the history of boron's early use in drugs, and the history of the use of boron
functional groups in medicinal chemistry applications are discussed. This includes …

Boron cluster compounds are inorganic compounds with chemical compositions and
structures vastly different from those of organic compounds, albeit with the ability to form a …

Icosahedral carboranes in medicine are still an emerging class of compounds with potential
beneficial applications in drug design. These highly hydrophobic clusters are potential “new …

There are two branches in boron medicinal chemistry: the first focuses on single boron atom
compounds, and the second utilizes boron clusters. Boron clusters and their heteroatom …

Proteolytic processing of viral polyproteins is essential for retrovirus infectivity. Retroviral
proteases (PR) become activated during or after assembly of the immature, non-infectious …

The use of the element boron, which is not generally observed in a living body, possesses a
high potential for the discovery of new biological activity in pharmaceutical drug design. In …

We report a series of 2′-deoxyribonucleoside triphosphates bearing dicarba-nido-
undecaborate ([C2B9H11] 1–),[3, 3′-iron-bis (1, 2-dicarbollide)]−(FESAN,[Fe (C2B9H11) 2] …

The chalcogen bond is a nonclassical σ‐hole‐based noncovalent interaction with emerging
applications in medicinal chemistry and material science. It is found in organic compounds …

Introduction: After decades of development, the medicinal chemistry of compounds that
contain a single boron atom has matured to the present status of having equal rights with …